Ligand Pharmaceuticals Inc (LGND)

Investing Cash Flow

-$144.78M

TTM · Period ending: · USD

LGND logo

LGND Investing Cash Flow

Latest reported-$144.78M
LGND TTM Cash from Investing ($19.40M → -$144.78M)
High-resolution chart · PNG

LGND investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
6,317,000
4,819,000
14,651,000
8,016,000
-27,026,000
-21,197,000
-24,900,000
-46,600,000
-13,100,000
-11,800,000
-28,600,000
-3,000,000
-500,000
-5,000,000
4,300,000
-5,700,000
-4,300,000
-4,200,000
7,500,000
19,600,000
16,900,000
32,000,000
21,700,000
19,800,000
19,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.